Albendazole-induced liver injury of a 11-year-old girl
https://doi.org/10.31146/1682-8658-ecg-171-11-83-88
Abstract
A case of the drug-induced liver injury (DILI) development is presented on the background of the self-treatment with an antiparasitic drug Albendazole in an 11 years-old girl with several risk factors for the drug-induced liver injury (history of a drug reaction, carbohydrate and fat metabolism disturbance, female gender, and adolescence). The disease was diagnosed using the the CIOMS/RUCAM scale. The drug was withdrawn and the pathogenetic therapy was established (fluids, hepatoprotective drugs) with the resolution of the drug-induced hepatitis.
About the Authors
S. N. Borzakova
Russian National Research Medical University N. I. Pirogov, Ministry of Health of Russia
Russian Federation
Russian Federation
L. A. Kharitonova
Russian National Research Medical University N. I. Pirogov, Ministry of Health of Russia
Russian Federation
Russian Federation
M. N. Ermakova
Children΄s City Clinical Hospital Z. A. Bashlyaevoy
Russian Federation
Russian Federation
I. M. Osmanov
Children΄s City Clinical Hospital Z. A. Bashlyaevoy
Russian Federation
Russian Federation
E. V. Rudikova
Children΄s City Clinical Hospital Z. A. Bashlyaevoy
Russian Federation
Russian Federation
Review
For citations:
Borzakova S.N., Kharitonova L.A., Ermakova M.N., Osmanov I.M., Rudikova E.V. Albendazole-induced liver injury of a 11-year-old girl. Experimental and Clinical Gastroenterology. 2019;(11):83-88. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-171-11-83-88
Views:
671
Email this article 